- 同花顺特色产品
- 〈高级诊股〉全方位深度分析，提供明确投资建议
- 〈舆情监控〉实时监控个股情报
- 短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
- 中期趋势：
上涨趋势有所减缓，可适量高抛低吸。
- 长期趋势：
迄今为止，共5家主力机构，持仓量总计2.14亿股，占流通A股36.36%
- 波段诊断：
-
技术面诊股
诊断结果：7.1技术面打败了66%的股票
技术面评分前10的股票
近期的平均成本为8.12元，股价在成本下方运行。多头行情中，上涨趋势有所减缓，可适量做高抛低吸。
平均成本
近期的平均成本为8.12元，股价在成本下方运行。
[{"text":"\u5e73\u5747\u6210\u672c","value":"8.12","date":1614239620,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑赢大盘，接近行业平均水平。
[{"date":"2021.02.26","stock":"-1.35","trade":"-0.40","ind":"-2.17"},{"date":"2021.02.25","stock":"-0.12","trade":"-1.11","ind":"-0.28"},{"date":"2021.02.24","stock":"-1.33","trade":"-0.82","ind":"-2.44"},{"date":"2021.02.23","stock":"1.47","trade":"-0.22","ind":"-0.61"},{"date":"2021.02.22","stock":"-0.24","trade":"0.38","ind":"-3.07"},{"date":"2021.02.19","stock":"1.24","trade":"1.66","ind":"0.35"},{"date":"2021.02.18","stock":"1.38","trade":"1.22","ind":"-1.22"},{"date":"2021.02.10","stock":"-0.13","trade":"1.76","ind":"2.12"},{"date":"2021.02.09","stock":"3.50","trade":"2.26","ind":"2.36"},{"date":"2021.02.08","stock":"2.66","trade":"0.40","ind":"1.75"},{"date":"2021.02.05","stock":"0.27","trade":"-0.04","ind":"-0.65"},{"date":"2021.02.04","stock":"-2.47","trade":"-2.13","ind":"-0.84"},{"date":"2021.02.03","stock":"-1.54","trade":"-1.93","ind":"-0.67"},{"date":"2021.02.02","stock":"0.13","trade":"0.62","ind":"2.07"},{"date":"2021.02.01","stock":"1.43","trade":"0.93","ind":"1.36"},{"date":"2021.01.29","stock":"-1.28","trade":"-1.39","ind":"-0.61"},{"date":"2021.01.28","stock":"-1.89","trade":"-1.31","ind":"-3.25"},{"date":"2021.01.27","stock":"0.51","trade":"-0.25","ind":"0.40"},{"date":"2021.01.26","stock":"-1.86","trade":"-1.38","ind":"-2.28"},{"date":"2021.01.25","stock":"-1.95","trade":"-2.10","ind":"0.52"},{"date":"2021.01.22","stock":"0.24","trade":"-0.05","ind":"0.70"}]
九芝堂,深证成指,中药指数
压力支撑
该股压力位为8.08元，支撑位为7.96元。
[{"text":"\u538b\u529b\u4f4d","value":"8.08","date":1614268800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"7.96","date":1614268800,"color":"0x0b52a1"}]
多空趋势
多头行情中，上涨趋势有所减缓，可适量做高抛低吸。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：6.0资金面打败了87%的股票
主力控盘前10的股票
行业资金
中药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：02月26日 20:30
| 机构今日流向(万元) | -64.38 | 机构5日流向(万元) | -5289.17 |
| 机构10日流向(万元) | -5116.56 | 机构20日流向(万元) | -11417.34 |
机构持仓
2020-09-30 与 2020-06-30 相比，主力机构持仓量增加1853.50万股，其中基金数没有增加，主力净减仓19家，暂未发现中长期投资价值。
截止2020-09-30，共5家主力机构（一般法人5家），持仓量总计21407.27万股，占流通A股36.36%
其中，基金持仓与2020-06-30相比：
增仓：0家 ，增持 0万股
减仓：0家 ，减持 0万股
新出现在主力名单中：1家 ，持有2941.22万股
从主力名单中消失：20家 ，原持有661.2万股
其中，基金持仓与2020-06-30相比：
增仓：0家 ，增持 0万股
减仓：0家 ，减持 0万股
新出现在主力名单中：1家 ，持有2941.22万股
从主力名单中消失：20家 ，原持有661.2万股
消息面诊股
诊断结果：8.4消息面打败了94%的股票
今日有利好新闻的公司
近期该股利好消息较多，投资者可加强关注。
更多>>个股资讯
- 九芝堂：2月25日融资净偿还248.75万元 上一
2021-02-26 - 九芝堂：2月24日融资净偿还156.47万元 上一
2021-02-25 - 九芝堂：2月23日融资净买入150.51万元 环比
2021-02-24 - 九芝堂：2月22日融资净买入141.64万元 上一
2021-02-23 - 九芝堂主力资金持续净流入，3日共净流入1086.2
2021-02-22 - 九芝堂连续5日获得北上资金净买入，累计买入824.
2021-02-22 - 九芝堂：2月19日融资净偿还20.65万元 上一交
2021-02-22 - 新修订！六味地黄类药物说明书增加多种不良反应
2021-02-19 - 药监局点名“六味地黄”们修改说明书 这些人群要注意
2021-02-19 - 九芝堂：2月18日融资净买入163.20万元 上一
2021-02-19
消息列表
| 重大利好 | 业绩预告 | 业绩大幅上升 | 2021-01-15 |
| 一般消息 | 股东大会 | 临时股东大会 | 2020-12-12 |
| 一般消息 | 分红转增 | 不分配不转增 | 2020-08-15 |
| 一般消息 | 重大事项 | 关联交易 | 2020-07-24 |
| 一般消息 | 高管变动 | 个人原因 | 2020-07-09 |
| 一般消息 | 高管变动 | 个人原因 | 2020-05-29 |
| 利好 | 分红转增 | 10派4.00元(含税) | 2020-04-30 |
| 利空 | 重大事项 | 公司违规：处罚类型 | 2020-04-18 |
| 一般消息 | 高管变动 | 因工作原因 | 2020-03-18 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2020-03-18 |
| 一般消息 | 重大事项 | 关联交易 | 2020-02-28 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 1条 | 1条 |
| 利空 | 1条 | 0条 | 1条 |
行业面诊股
诊断结果：8.0行业面打败了55%的股票
中药行业最新资金流向
近10日来该行业走势明显向上，明显跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势明显向上，明显跑赢大盘。
[{"date":"2021.02.26","price":"-2.17","value":"-0.40"},{"date":"2021.02.25","price":"-0.28","value":"-1.11"},{"date":"2021.02.24","price":"-2.44","value":"-0.82"},{"date":"2021.02.23","price":"-0.61","value":"-0.22"},{"date":"2021.02.22","price":"-3.07","value":"0.38"},{"date":"2021.02.19","price":"0.35","value":"1.66"},{"date":"2021.02.18","price":"-1.22","value":"1.22"},{"date":"2021.02.10","price":"2.12","value":"1.76"},{"date":"2021.02.09","price":"2.36","value":"2.26"},{"date":"2021.02.08","price":"1.75","value":"0.40"},{"date":"2021.02.05","price":"-0.65","value":"-0.04"},{"date":"2021.02.04","price":"-0.84","value":"-2.13"},{"date":"2021.02.03","price":"-0.67","value":"-1.93"},{"date":"2021.02.02","price":"2.07","value":"0.62"},{"date":"2021.02.01","price":"1.36","value":"0.93"},{"date":"2021.01.29","price":"-0.61","value":"-1.39"},{"date":"2021.01.28","price":"-3.25","value":"-1.31"},{"date":"2021.01.27","price":"0.40","value":"-0.25"},{"date":"2021.01.26","price":"-2.28","value":"-1.38"},{"date":"2021.01.25","price":"0.52","value":"-2.10"},{"date":"2021.01.22","price":"0.70","value":"-0.05"}]
深证成指,中药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 贵州百灵 | 13.89% | 1.79% | 6.4分 |
| 2 | 嘉应制药 | 12.87% | 12.16% | 6.3分 |
| 3 | *ST目药 | 11.08% | 2.50% | 5.7分 |
| 4 | 康缘药业 | 11.03% | 3.77% | 6.3分 |
| 5 | 太极集团 | 8.01% | 2.87% | 6.7分 |
| 6 | 同仁堂 | 7.27% | 1.81% | 6.4分 |
| 8 | 仁和药业 | 2.56% | 2.56% | 6.0分 |
| 10 | 益佰制药 | 1.78% | -2.46% | 6.6分 |
| 12 | 千金药业 | 1.41% | -0.92% | 6.4分 |
| 14 | 新天药业 | 0.44% | -0.87% | 6.1分 |
| 16 | 中新药业 | -0.17% | -2.13% | 6.0分 |
| 18 | 江中药业 | -0.47% | -2.49% | 6.2分 |
| 20 | 华润三九 | -0.61% | -2.89% | 6.3分 |
| 22 | 片仔癀 | -0.69% | -22.32% | 4.7分 |
| 24 | 珍宝岛 | -0.93% | -0.84% | 5.7分 |
| 26 | 九芝堂 | -1.83% | -1.59% | 7.1分 |
| 28 | 紫鑫药业 | -2.49% | 0.37% | 5.7分 |
| 30 | 天士力 | -2.64% | -1.96% | 5.9分 |
| 32 | 东阿阿胶 | -3.03% | -13.84% | 4.0分 |
| 34 | 盘龙药业 | -3.17% | 0.35% | 6.1分 |
| 36 | 华森制药 | -3.91% | -2.42% | 6.1分 |
| 38 | 葵花药业 | -4.08% | -2.01% | 5.6分 |
| 40 | 精华制药 | -4.30% | 1.83% | 6.2分 |
| 42 | 方盛制药 | -5.34% | -1.91% | 5.9分 |
| 44 | 维康药业 | -5.72% | -6.14% | 5.1分 |
| 46 | 易明医药 | -6.25% | -0.83% | 5.8分 |
| 48 | 佐力药业 | -7.73% | -2.99% | 6.1分 |
| 50 | 贵州三力 | -8.16% | -2.52% | 5.1分 |
| 52 | 佛慈制药 | -9.31% | -4.48% | 4.9分 |
| 54 | 葫芦娃 | -9.64% | -2.66% | 5.5分 |
| 56 | 众生药业 | -9.87% | -7.15% | 5.6分 |
| 58 | 大理药业 | -10.34% | -0.55% | 5.2分 |
| 60 | 上海凯宝 | -11.48% | -1.96% | 4.9分 |
| 62 | 以岭药业 | -15.21% | -1.72% | 6.1分 |
| 64 | 桂林三金 | -18.00% | -1.35% | 5.9分 |
| 66 | 西藏药业 | -19.16% | -7.48% | 5.0分 |
| 68 | 健民集团 | -21.48% | -6.96% | 5.1分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2020-09-30 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 36/131 ， 32/131。
[{"date":"2020-09-30","value":"5.80","vol":"5.26"},{"date":"2020-06-30","value":"5.03","vol":"4.02"},{"date":"2020-03-31","value":"2.21","vol":"1.94"},{"date":"2019-12-31","value":"4.64","vol":"7.14"},{"date":"2019-09-30","value":"4.56","vol":"7.01"}]
| 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
5.80 | 5.03 | 2.21 | 4.64 | 4.56 |
| 行业(%) | 5.26 | 4.02 | 1.94 | 7.14 | 7.01 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2020-09-30","value":"61.20","vol":"56.07"},{"date":"2020-06-30","value":"62.32","vol":"55.88"},{"date":"2020-03-31","value":"61.79","vol":"55.38"},{"date":"2019-12-31","value":"61.55","vol":"57.87"},{"date":"2019-09-30","value":"61.82","vol":"59.05"}]
| 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
61.20 | 62.32 | 61.79 | 61.55 | 61.82 |
| 行业(%) | 56.07 | 55.88 | 55.38 | 57.87 | 59.05 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 9/131 ， 12/131。
[{"date":"2020-09-30","value":"13.15","vol":"-7.19"},{"date":"2020-06-30","value":"8.55","vol":"-11.10"},{"date":"2020-03-31","value":"-4.29","vol":"-14.27"},{"date":"2019-12-31","value":"0.68","vol":"6.86"},{"date":"2019-09-30","value":"-7.69","vol":"7.17"}]
| 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
13.15 | 8.55 | -4.29 | 0.68 | -7.69 |
| 行业(%) | -7.19 | -11.10 | -14.27 | 6.86 | 7.17 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2020-09-30","value":"20.78","vol":"-147.45"},{"date":"2020-06-30","value":"11.71","vol":"-60.36"},{"date":"2020-03-31","value":"10.43","vol":"-33.89"},{"date":"2019-12-31","value":"-42.90","vol":"-26.74"},{"date":"2019-09-30","value":"-43.54","vol":"13.08"}]
| 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
20.78 | 11.71 | 10.43 | -42.90 | -43.54 |
| 行业(%) | -147.45 | -60.36 | -33.89 | -26.74 | 13.08 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 14/131 ， 32/131。
[{"date":"2020-09-30","value":"0.53","vol":"0.42"},{"date":"2020-06-30","value":"0.37","vol":"0.28"},{"date":"2020-03-31","value":"0.18","vol":"0.13"},{"date":"2019-12-31","value":"0.63","vol":"0.68"},{"date":"2019-09-30","value":"0.46","vol":"0.47"}]
| 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.53 | 0.37 | 0.18 | 0.63 | 0.46 |
| 行业(次) | 0.42 | 0.28 | 0.13 | 0.68 | 0.47 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2020-09-30","value":"1.73","vol":"2.06"},{"date":"2020-06-30","value":"1.17","vol":"1.30"},{"date":"2020-03-31","value":"0.59","vol":"0.62"},{"date":"2019-12-31","value":"2.13","vol":"3.05"},{"date":"2019-09-30","value":"1.61","vol":"2.13"}]
| 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
1.73 | 1.17 | 0.59 | 2.13 | 1.61 |
| 行业(次) | 2.06 | 1.30 | 0.62 | 3.05 | 2.13 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2020-09-30","value":"23.03","vol":"9.28"},{"date":"2020-06-30","value":"25.46","vol":"18.87"},{"date":"2020-03-31","value":"7.05","vol":"9.14"},{"date":"2019-12-31","value":"26.86","vol":"18.29"},{"date":"2019-09-30","value":"23.23","vol":"12.01"}]
| 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 23.03 | 25.46 | 7.05 | 26.86 | 23.23 |
| 行业 | 9.28 | 18.87 | 9.14 | 18.29 | 12.01 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2020-09-30","value":"","vol":"0.00"},{"date":"2020-06-30","value":"0.54","vol":"1.74"},{"date":"2020-03-31","value":"","vol":"0.00"},{"date":"2019-12-31","value":"1.34","vol":"2.34"},{"date":"2019-09-30","value":"","vol":"0.00"}]
| 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.54 | - | 1.34 | - |
| 行业 | 0.00 | 1.74 | 0.00 | 2.34 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 21/131 ， 33/131。
[{"date":"2020-09-30","value":"2.42","vol":"3.23"},{"date":"2020-06-30","value":"2.45","vol":"3.17"},{"date":"2020-03-31","value":"2.85","vol":"3.31"},{"date":"2019-12-31","value":"3.00","vol":"3.13"},{"date":"2019-09-30","value":"2.83","vol":"3.09"}]
| 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
2.42 | 2.45 | 2.85 | 3.00 | 2.83 |
| 行业 | 3.23 | 3.17 | 3.31 | 3.13 | 3.09 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2020-09-30","value":"1.83","vol":"2.53"},{"date":"2020-06-30","value":"1.84","vol":"2.43"},{"date":"2020-03-31","value":"2.17","vol":"2.56"},{"date":"2019-12-31","value":"2.21","vol":"2.43"},{"date":"2019-09-30","value":"1.59","vol":"2.27"}]
| 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
1.83 | 1.84 | 2.17 | 2.21 | 1.59 |
| 行业 | 2.53 | 2.43 | 2.56 | 2.43 | 2.27 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 43/131 ， 45/131。
[{"date":"2020-09-30","value":"23.91","vol":"32.56"},{"date":"2020-06-30","value":"23.28","vol":"32.88"},{"date":"2020-03-31","value":"20.34","vol":"31.53"},{"date":"2019-12-31","value":"18.61","vol":"31.60"},{"date":"2019-09-30","value":"19.59","vol":"29.38"}]
| 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
23.91 | 23.28 | 20.34 | 18.61 | 19.59 |
| 行业(%) | 32.56 | 32.88 | 31.53 | 31.60 | 29.38 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2020-09-30","value":"0.31","vol":"0.83"},{"date":"2020-06-30","value":"0.30","vol":"0.76"},{"date":"2020-03-31","value":"0.26","vol":"0.72"},{"date":"2019-12-31","value":"0.23","vol":"0.70"},{"date":"2019-09-30","value":"0.24","vol":"0.62"}]
| 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.31 | 0.30 | 0.26 | 0.23 | 0.24 |
| 行业(%) | 0.83 | 0.76 | 0.72 | 0.70 | 0.62 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2020年的收益，请投资者后续关注。
[{"date":"2016","yellowRectValue":"6.52","blueLineValue":"","type":""},{"date":"2017","yellowRectValue":"7.12","blueLineValue":"","type":""},{"date":"2018","yellowRectValue":"3.36","blueLineValue":"","type":""},{"date":"2019","yellowRectValue":"1.92","blueLineValue":"","type":""},{"date":"2020","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]